secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2025-09-08T23:59:59+00:00
Accession:  0001558370-25-011911
Event type: regulatory
Sentiment:  positive
Materiality: 0.70
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Coherus Oncology regains Nasdaq compliance after bid price shortfall
--------------------------------------------------------------------

- On June 30, 2025, Coherus received a Nasdaq deficiency notice for bid price below $1.00 for 30 consecutive business days.
- Company had 180 days, until December 29, 2025, to regain compliance.
- On September 5, 2025, Nasdaq confirmed Coherus's closing price was $1.00 or greater for the requisite period.
- Company is now in full compliance with all Nasdaq continued listing standards; matter is closed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025011911/0001558370-25-011911-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837025011911/chrs-20250905x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-011911

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer